Synthesis and Crystal Structure of Chiral (1R,5R)-3-Arylidenopinones

被引:0
作者
Yang, Yi-Qin [1 ]
Xu, Hai-Jun [2 ]
Lan, Lan [1 ]
Wang, Shi-Fa [1 ,2 ]
机构
[1] Nanjing Forestry Univ, Inst Chem Engn, Inst Light Ind Sci & Engn, Nanjing 210037, Jiangsu, Peoples R China
[2] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Key Lab Biomass Based Green Fuels & Chem, Nanjing 210037, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
(1S; 5S)-(-)-beta; -pinene; (1R; 5S)-(+)-nopinone; 5R)-(-)-3-arylideneno-pinones; Crystal structure; Synthesis; SUNSCREENS; IRRADIATION;
D O I
10.14233/ajchem.2013.14949
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Three (1R,5R)-(-)3-arylideneopinones (2a, 2b and 2c) were first synthesized and characterized by IR, MS, NMR, elemental analysis and single-crystal X-ray diffraction method. The structure indicates that the compound 2a belongs to orthorhombic, space group P2(1)2(1)2(1) with a = 1.0378 (5) nm, b = 1.1156 (6) nm, c = 1.2775 (7) nm, beta = 90 degrees. V = 1.4791 (13) nm(3), Z = 4, rho = 1.223 g cm(-3), mu = 0.083 mm(-1), F (000) = 584 and final R-1 = 0.0327, wR2 = 0.0876. The compound 2b belongs to trigonal, space group P3(2) with a = 0.93024(12) nm, b = 0.93024(12) nm, c = 1.3215(4) nm, beta = 90.0 degrees. V = 0.9903(3) nm(3), Z = 3, rho = 1.219 g cm(-3), mu = 0.079 mm(-1), F(000) = 390 and final R-1 = 0.0350, wR2 = 0.0912. The compound 2c belongs to monoclinic, space group P2(1) with a = 1.20252 (15) nm, b = 0.99228(12) nm, c = 2.3905(3) nm, beta = 92.769(2)degrees. V = 2.8491(6) nm(3), Z = 8, rho = 1.216 g cm(-3), mu = 0.254 mm(-1), F(000) = 1104 and final R-1 = 0.0440, wR2 = 0.1069.
引用
收藏
页码:7490 / 7494
页数:5
相关论文
共 11 条
[1]   THE CRYSTAL-STRUCTURE OF (DIPHENYL) (ETHYLXANTHOGENATE)IODANE, C15H15IOS2 [J].
BOZOPOULOS, AP ;
KAVOUNIS, CA ;
STERGIOUDIS, GS ;
RENTZEPERIS, PJ .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 1989, 187 (1-2) :97-102
[2]  
Chatelain E, 2001, PHOTOCHEM PHOTOBIOL, V74, P401, DOI 10.1562/0031-8655(2001)074<0401:POBMAA>2.0.CO
[3]  
2
[4]   Study of the photostability of 18 sunscreens in creams by measuring the SPF in vitro [J].
Couteau, Celine ;
Faure, Aurelie ;
Fortin, June ;
Paparis, Eva ;
Coiffard, Laurence J. M. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 44 (01) :270-273
[5]   Sun exposure, sunscreens, and skin cancer prevention: A year-round concern [J].
Farmer, KC ;
Naylor, MF .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) :662-673
[6]  
Gerard L, 1991, Tert-butyl derivatives of ben-zylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them, Patent No. [US 5000961, 5000961]
[7]   Photoprotective efficacy and photostability of fifteen sunscreen products having the same label SPF subjected to natural sunlight [J].
Hojerova, J. ;
Medovcikova, A. ;
Mikula, M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 408 (1-2) :27-38
[8]  
Sheldrick G.M., 1997, SHELXTL VERSION 5 10
[9]   Changes in ultraviolet absorption of sunscreens after ultraviolet irradiation [J].
Tarras-Wahlberg, N ;
Stenhagen, G ;
Larkö, O ;
Rosén, A ;
Wennberg, AM ;
Wennerström, O .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (04) :547-553
[10]   Solar UV irradiation and dermal photoaging [J].
Wlaschek, M ;
Tantcheva-Poór, I ;
Naderi, L ;
Ma, WJ ;
Schneider, A ;
Razi-Wolf, Z ;
Schüller, J ;
Scharffetter-Kochanek, K .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 63 (1-3) :41-51